https://www.pharmadoc.it/illegittima-la-determinazione-aifa-che-posticipa-la-classificazione-del-generico-di-mylan/ 2018-12-11T16:25:38+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/08/Pharmakit-news-4.jpg https://www.pharmadoc.it/combinazione-farmaci-in-dose-fissa-e-cpc-estensione-della-copertura-brevettuale-solo-a-determinate-condizioni/ 2018-12-11T16:27:05+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/08/Pharmakit-news-2.jpg https://www.pharmadoc.it/laccesso-alla-terapia-nutrizionale-personalizzazione-e-appropriatezza-delle-cure-nel-quadro-delle-nuove-normative-sugli-appalti/ 2018-12-13T13:36:09+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/12/locandina-verona-bianca-web-3.jpg https://www.pharmadoc.it/laccesso-alla-terapia-nutrizionale-personalizzazione-e-appropriatezza-delle-cure-nel-quadro-delle-nuove-normative-sugli-appalti-2/ 2018-12-13T15:26:08+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/12/Locandina-Evento-2018-Roma.jpg https://www.pharmadoc.it/corte-di-giustizia-sono-sanzionabili-le-condotte-di-roche-e-novartis-per-il-caso-avastin-lucentis/ 2019-01-03T11:53:40+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/12/Corte-di-Giustizia.jpeg https://www.pharmadoc.it/radiofarmaci-la-corte-di-giustizia-esclude-il-carattere-gratuito-della-convenzione-e-impone-la-gara/ 2019-01-03T12:02:43+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/12/Radiofarmaco.jpg https://www.pharmadoc.it/file-f-tra-spesa-farmaceutica-e-innovazione-terapeutica/ 2019-01-07T09:37:59+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/File-F-sito.jpg https://www.pharmadoc.it/ai-fini-del-rilascio-del-cpc-la-procedura-di-certificazione-della-conformita-ce-non-e-equiparabile-a-quella-dellaic/ 2019-01-10T12:05:36+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/11/shutterstock_1131162701.jpg https://www.pharmadoc.it/ritardato-ingresso-dei-farmaci-generici-sul-mercato-confermate-le-sanzioni-a-servier-biogaran-e-niche-per-condotte-anticoncorrenziali/ 2019-01-16T16:49:35+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/EU-Giustizia.jpg https://www.pharmadoc.it/la-concorrenza-possibile-tra-farmaco-coperto-da-brevetto-e-farmaco-ibrido/ 2019-01-24T16:47:59+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/siringa_preriempita.jpg https://www.pharmadoc.it/la-programmazione-aifa-per-il-2019-si-prefigura-uno-scossone-al-sistema-farmaco/ 2019-02-07T12:19:40+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/02/Public-Health.jpg https://www.pharmadoc.it/d-m-10-08-2018-le-linee-guida-per-le-procedure-di-acquisto-di-dispositivi-medici/ 2019-02-14T10:35:39+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/02/Copia-di-DM.jpg https://www.pharmadoc.it/farmaci-biosimilari-tra-contenimento-della-spesa-sanitaria-diritto-alla-salute-e-liberta-prescrittiva-del-medico/ 2019-04-10T09:02:55+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/04/Copia-di-contenimento-costi.jpg https://www.pharmadoc.it/nuove-modalita-di-acquisto-di-apparecchiature-sanitarie-noleggio-pay-per-use-ecc/ 2019-04-10T10:53:58+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/04/payperuse.jpg https://www.pharmadoc.it/il-regolamento-ue-2017-745-quali-ricadute-sullacquisto-di-dispositivi-medici/ 2019-04-10T10:56:12+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/03/shutterstock_506591185.jpg https://www.pharmadoc.it/al-via-la-produzione-dei-medicinali-biosimilari-e-generici-in-vigenza-del-cpc-approvata-la-modifica-al-regolamento-469-2009/ 2019-04-18T16:33:33+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/04/shutterstock_331288130.jpg https://www.pharmadoc.it/i-finanziamenti-dellindustria-del-farmaco-ai-medici-e-alla-ricerca-dal-rapporto-gimbe-al-sunshine-act/ 2019-04-29T08:46:48+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/04/shutterstock_691546588.jpg https://www.pharmadoc.it/gare-regionali-per-lacquisto-di-farmaci-in-equivalenza-terapeutica-determina-aifa-n-818-2018/ 2019-04-29T11:07:17+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/04/shutterstock_1061962874.jpg https://www.pharmadoc.it/la-sicurezza-nellacquisto-di-dispositivi-medici-infusionali-aghi-e-siringhe/ 2019-05-08T11:07:41+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/05/Copia-di-Siringhe.jpg https://www.pharmadoc.it/sevoflurano-criteri-di-aggiudicazione-e-sicurezza-dei-dispositivi-accessori-nelle-procedure-di-gara/ 2019-05-17T14:42:21+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/05/Gas-anestetico.jpg https://www.pharmadoc.it/il-concetto-di-ultima-generazione-nei-bandi-di-gara-per-lacquisto-dei-dispositivi-medici-e-di-apparecchiature-sanitarie/ 2019-05-22T09:33:27+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/05/Copia-di-DM-nuova-generazione.jpg https://www.pharmadoc.it/epoetina-alfa-beta-e-zeta-di-nuovo-in-un-lotto-unico/ 2019-05-23T12:49:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/09/Sede-Consip-Roma.jpg https://www.pharmadoc.it/ossigeno-terapeutico-illegittimita-della-determinazione-in-via-autoritativa-del-prezzo/ 2019-05-23T12:53:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/11/aifa-505235.jpg https://www.pharmadoc.it/vaccini-spetta-unicamente-alle-regioni-decidere-sullequivalenza-profilattica/ 2019-05-23T12:56:56+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/11/medicine-salute-vaccino.jpg https://www.pharmadoc.it/avastin-roche-lucentis-novartis-nuova-pronuncia-della-corte-di-giustizia-ue-a-favore-delluso-off-label-di-avastin/ 2019-05-23T12:59:14+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/12/Corte-di-Giustizia-dellUnione-europea-Lussemburgo.jpg https://www.pharmadoc.it/gare-di-appalto-pubblica-amministrazione-tra-discrezionalita-ed-eccesso-di-potere-lapplicazione-dellaccordo-quadro-nellacquisto-di-farmaci-biologici/ 2019-05-23T13:00:55+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/soldiefarmaci.jpg https://www.pharmadoc.it/gare-per-biosimilari-prevale-lutilizzo-dellaccordo-quadro-il-caso-delle-epoetine/ 2019-05-23T13:08:53+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/Accordo-quadro-garesito.jpg https://www.pharmadoc.it/fattore-viii-e-lotto-unico-il-consiglio-di-stato-tiene-in-piedi-la-gara/ 2019-05-23T13:11:35+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/Fattore-VIII.jpg https://www.pharmadoc.it/aumenta-nel-2018-il-contenzioso-sul-mercato-parallelo-dei-farmaci/ 2019-05-23T13:14:11+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/02/Circolazione-europea.jpg https://www.pharmadoc.it/intercambiabilita-copemyl-copaxone-il-consiglio-di-stato-da-ragione-ad-aifa/ 2019-05-23T13:17:51+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/02/Copia-di-Consiglio-Stato.jpg https://www.pharmadoc.it/dispositivi-medici-qualita-o-prezzo-nei-capitolati-di-gara/ 2019-05-23T14:16:59+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/03/Dispositivi2.jpg https://www.pharmadoc.it/il-nuovo-dg-dellaifa-contro-le-clausole-di-riservatezza-nella-contrattazione-del-prezzo-dei-farmaci/ 2019-05-23T14:18:02+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/03/Copia-di-AIFA_palazzo-2.jpg https://www.pharmadoc.it/d-l-n-32-2019-sbloccacantieri-nuove-opportunita-per-lacquisto-di-farmaci-e-dispositivi-medici/ 2019-05-27T10:48:30+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/05/shutterstock_141768178.jpg https://www.pharmadoc.it/trasparenza-o-confidenzialita-dei-prezzi-dei-farmaci-il-gioco-delle-parti/ 2019-06-10T15:59:36+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/06/commissione-gara.jpg https://www.pharmadoc.it/wp-content/uploads/2019/06/Schermata-2019-06-10-alle-17.58.36.png https://www.pharmadoc.it/wp-content/uploads/2019/06/Schermata-2019-06-10-alle-17.02.31.png https://www.pharmadoc.it/wp-content/uploads/2019/06/Schermata-2019-06-10-alle-12.17.22.png https://www.pharmadoc.it/medicinali-orfani-il-giudice-europeo-delinea-i-criteri-per-lassegnazione-della-classificazione/ 2019-06-13T13:57:07+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/06/Copia-di-MARTELLETTO-EUROPA.jpg https://www.pharmadoc.it/analisi-giurisprudenziale-sullaic-pubblicato-online-su-www-giuripharma-it/ 2019-07-02T11:08:23+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/07/shutterstock_248156353.jpg https://www.pharmadoc.it/wp-content/uploads/2019/07/Schermata-2019-06-26-alle-15.40.12.png https://www.pharmadoc.it/wp-content/uploads/2019/07/Schermata-2019-06-26-alle-15.35.55.png https://www.pharmadoc.it/wp-content/uploads/2019/07/Schermata-2019-07-02-alle-11.06.41.png https://www.pharmadoc.it/convertito-in-legge-con-modifiche-significative-il-decreto-sbloccacantieri/ 2019-07-08T12:54:53+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/07/Copia-di-appalto.jpg https://www.pharmadoc.it/il-lunedi-nero-di-novartis-e-roche-la-doppia-pronuncia-del-consiglio-di-stato-sul-caso-lucentis-avastin/ 2019-07-17T13:58:16+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/07/Antitrus-law-3.png https://www.pharmadoc.it/la-consultazione-preliminare-di-mercato-e-laffidamento-diretto-nelle-forniture-di-dispositivi-medici/ 2019-07-24T08:39:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/07/Copia-di-Dispositivi3.jpg https://www.pharmadoc.it/decadenza-dal-marchio-per-mancato-uso-la-particolare-circostanza-delle-sperimentazioni-cliniche/ 2019-07-24T15:17:11+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/07/Copia-di-Brand.jpg https://www.pharmadoc.it/la-tematica-dellequivalenza-disequivalenza-terapeutica-e-sempre-di-attualita-il-cds-ribalta-due-sentenze-tar/ 2019-08-02T07:24:17+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/08/Copia-di-Antitrust.jpg https://www.pharmadoc.it/e-online-in-giuripharma-it-il-nuovo-giuridoc-sul-tema-dei-farmaci-orfani/ 2019-08-29T13:10:08+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/08/farmaci-orfani.jpg https://www.pharmadoc.it/contenzioso-contro-aifa-confronto-2018-i-semestre-2019/ 2019-08-29T13:37:04+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/08/AIFA_INGRESSO.jpg https://www.pharmadoc.it/wp-content/uploads/2019/08/Schermata-2019-08-29-alle-12.22.40.png https://www.pharmadoc.it/wp-content/uploads/2019/08/Schermata-2019-08-28-alle-17.18.42.png https://www.pharmadoc.it/wp-content/uploads/2019/08/Schermata-2019-08-28-alle-17.43.52.png https://www.pharmadoc.it/wp-content/uploads/2019/08/Schermata-2019-08-29-alle-12.21.47.png https://www.pharmadoc.it/wp-content/uploads/2019/08/Schermata-2019-08-29-alle-11.56.54.png https://www.pharmadoc.it/wp-content/uploads/2019/08/Schermata-2019-08-29-alle-12.16.27.png https://www.pharmadoc.it/farmaci-equivalenti-aumentano-i-volumi-ma-e-a-rischio-la-redditivita/ 2019-09-09T12:41:50+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/09/Copia-di-Growth_custom.jpg https://www.pharmadoc.it/i-programmi-di-horizon-scanning-europei-e-il-rapporto-aifa-sui-nuovi-farmaci/ 2019-09-10T14:01:12+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/09/Copia-di-Horizon-scanning.jpg https://www.pharmadoc.it/wp-content/uploads/2019/09/1.png https://www.pharmadoc.it/wp-content/uploads/2019/09/2.png https://www.pharmadoc.it/wp-content/uploads/2019/09/3.png https://www.pharmadoc.it/wp-content/uploads/2019/09/4.png https://www.pharmadoc.it/wp-content/uploads/2019/09/5.png https://www.pharmadoc.it/designazione-orfana-la-diversita-di-eccipienti-quale-elemento-distintivo-tra-medicinali/ 2019-09-23T10:19:00+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/09/farmaci-orfani-2.jpg https://www.pharmadoc.it/la-clausola-di-revisione-periodica-del-prezzo-nei-contratti-ad-esecuzione-periodica-e-continuativa-applicazione-e-criticita/ 2019-09-23T10:32:39+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/09/shutterstock_180990968.jpg https://www.pharmadoc.it/biosimilari-il-position-paper-di-farmindustria/ 2019-10-29T14:30:55+00:00 https://www.pharmadoc.it/wp-content/uploads/2018/12/Generici-biosimilari.jpg https://www.pharmadoc.it/sostituibilita-automatica-tra-biosimilari-aifa-spinge-per-la-riforma-normativa/ 2019-10-29T15:57:43+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/10/comparison-drugs.jpg https://www.pharmadoc.it/il-rapporto-rischio-beneficio-probatio-diabolica-per-le-aziende-farmaceutiche-il-caso-della-sospensione-dellaic-per-i-prodotti-a-base-di-gadolinio/ 2019-10-29T15:58:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/10/Patient-safety-1.jpg https://www.pharmadoc.it/mancata-aderenza-alla-terapia-e-sviluppo-delle-patologie-croniche-attuazione-regionale-del-piano-nazionale-cronicita/ 2019-11-25T16:10:49+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/10/Cronicita-e-aderenza.jpg https://www.pharmadoc.it/biosimilari-intercambiabilita-e-liberta-prescrittiva-la-regione-toscana-grazie-ai-ricorsi-trova-il-giusto-equilibrio/ 2019-11-28T15:24:21+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/11/prescrizione.jpg https://www.pharmadoc.it/equivalenza-terapeutica-col-v-livello-atc-per-i-fattori-viii-il-cds-per-il-lotto-semplice-competitivo/ 2020-01-29T13:06:41+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/01/emoderivati-copia.jpg https://www.pharmadoc.it/ossigeno-terapeutico-sanzionate-le-pratiche-anticoncorrenziali/ 2020-02-05T14:12:07+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/02/ossigenoterapia.jpg https://www.pharmadoc.it/autorizzazione-allimmissione-in-commmercio-dei-medicinali-sancito-dalla-corte-di-giustizia-ue-il-diritto-di-accesso-al-dossier-registrativo/ 2020-02-13T17:19:23+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/02/accesso-agli-atti-EMA.jpg https://www.pharmadoc.it/wp-content/uploads/2020/02/TIPOLOGIA-ATTI2.png https://www.pharmadoc.it/wp-content/uploads/2020/02/Esiti-del-contendere.png https://www.pharmadoc.it/nuovi-ricorsi-avverso-il-payback/ 2020-02-14T20:51:55+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/02/payback.jpg https://www.pharmadoc.it/wp-content/uploads/2020/02/Grafico-1.png https://www.pharmadoc.it/sistemi-di-erogazione-di-un-farmaco-e-lotti-di-gara-siringa-preriempita-e-penna-preriempita-per-me-pari-sono-secondo-il-cds/ 2020-03-10T15:20:35+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/03/93466683_xl-penna-adrenalina.jpg https://www.pharmadoc.it/limpegno-dellindustria-farmaceutica-per-contrastare-il-covid-19/ 2020-03-13T11:46:05+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/03/141432640_xv-coronavirus.jpg https://www.pharmadoc.it/wp-content/uploads/2020/03/Tabella-1.png https://www.pharmadoc.it/wp-content/uploads/2020/03/centri-1.png https://www.pharmadoc.it/wp-content/uploads/2020/03/Tab-3-prodotti.png https://www.pharmadoc.it/wp-content/uploads/2020/03/Tab-01.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-02.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-03.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-04.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-05.png https://www.pharmadoc.it/wp-content/uploads/2020/03/Tab-06.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-07.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-08.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-09.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab10.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-11.png https://www.pharmadoc.it/wp-content/uploads/2020/03/tab-12.png https://www.pharmadoc.it/i-farmaci-sperimentali-e-off-label/ 2020-03-23T07:47:29+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/03/140517804_xl-farmaci-off-label.jpg https://www.pharmadoc.it/aifa-e-aziende-farmaceutiche-a-lavoro-in-remoto-per-la-verifica-in-contraddittorio-degli-oneri-dovuti-a-titolo-di-payback-per-lanno-2018/ 2020-04-10T15:49:25+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/04/Payback-copia.jpg https://www.pharmadoc.it/cambiano-le-regole-per-cts-e-cpr/ 2020-05-12T12:29:07+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/05/Magrini.png https://www.pharmadoc.it/la-dematerializzazione-della-ricetta-anche-per-gli-stupefacenti-agevola-il-lavoro-del-mmg-e-perfeziona-ulteriormente-il-distanziamento-clinico-domiciliare/ 2020-05-19T09:34:09+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/05/RICETTA-DEMATERIALIZ_63440003_xl-copia.jpg https://www.pharmadoc.it/l-amministratore-unico-di-pharmadoc-racconta-il-nuovo-format/ 2020-06-11T09:43:21+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/cover-rossana-linkedin.jpg https://www.pharmadoc.it/comunicare-con-la-pubblica-amministrazione-in-tempo-di-pandemia/ 2020-06-11T10:48:50+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/Cover-Dott.ssa-Proli.jpg https://www.pharmadoc.it/linformazione-scientifica-in-tempo-di-pandemia/ 2020-06-24T07:26:16+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/PHARMA-Interview_-Cover-De-Rosa-2.png https://www.pharmadoc.it/la-gestione-pandemica-dei-farmaci-nel-decreto-liquidita/ 2020-06-24T07:26:44+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/Cover-Bellavia.jpg https://www.pharmadoc.it/covid-19-risposte-dalle-direzioni-generali/ 2020-06-25T09:13:09+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/Cover-tanese-1.jpg https://www.pharmadoc.it/flussi-e-controlli-su-registri-aifa-e-innovativi-farmacia-tra-clinica-ed-economia/ 2020-06-30T17:48:16+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/Cover-beltramini-min.jpg https://www.pharmadoc.it/un-farmacista-sempre-in-prima-linea-nelle-emergenze-sanitarie-norme-dpi-e-linee-guida-oms/ 2020-07-06T17:26:32+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Cover-Di-Muzio.jpg https://www.pharmadoc.it/dd-e-dpc-il-mix-e-il-top/ 2020-07-14T13:42:48+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Cover-BIANCHI.jpg https://www.pharmadoc.it/file-f-da-mera-rendicontazione-a-strumento-di-ricerca-anche-per-farmaci-innovativi/ 2020-07-22T18:29:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Cover-Ladisa-copia.jpg https://www.pharmadoc.it/liberta-prescrittiva-e-orientamento-motivazionista-torna-la-libera-scelta-del-medico/ 2020-07-27T11:47:13+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Liberta-prescrittiva-45303158_xl-copia.jpg https://www.pharmadoc.it/il-consiglio-di-stato-ribalta-se-stesso-il-v-livello-atc-non-e-sufficiente-per-il-fattore-viii-e-fattore-ix-deve-pronunciarsi-aifa/ 2020-07-28T14:22:26+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Fattore-VIII.jpeg https://www.pharmadoc.it/prontuari-ostacoli-allaccesso-o-strumenti-di-governance-farmaceutica/ 2020-07-30T16:12:31+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/Cover-miceli-sopo.jpg https://www.pharmadoc.it/con-lo-stop-della-fda-si-riducono-le-speranze-di-avere-subito-una-terapia-genica-per-i-pazienti-con-emofilia-a/ 2020-08-27T15:38:37+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/08/terapia-genica.jpeg https://www.pharmadoc.it/wp-content/uploads/2020/08/Evaluate-vantage.png https://www.pharmadoc.it/wp-content/uploads/2020/08/ADcom.png https://www.pharmadoc.it/la-pandemia-vista-dal-piu-importante-polo-logistico-pubblico-del-nord/ 2020-09-07T17:19:50+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/PHARMA-Interview_-Santachiara-copia.jpg https://www.pharmadoc.it/genazzani-al-chmp-di-ema/ 2020-09-12T08:07:07+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/09/Gennazzani-Armando-2.png https://www.pharmadoc.it/wp-content/uploads/2020/09/Gennazzani-1.png https://www.pharmadoc.it/la-riorganizzazione-logistica-imposta-dalla-pandemia-in-regione-campania/ 2020-09-24T10:13:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/09/PHARMA-Interview_Cristinziano-1-min.jpg https://www.pharmadoc.it/esortazione-ue-affidamenti-multi-fornitore-e-valutazione-di-elementi-qualitativi-nelle-gare-di-appalto-per-i-farmaci-in-funzione-della-sicurezza-di-approvvigionamento/ 2020-10-13T07:41:28+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/10/EU-esortazione-EU-acquisto-farmaci.jpg https://www.pharmadoc.it/patent-linkage-e-cpc-novita-di-rilievo-per-generici-e-biosimilari-ma-non-per-litalia/ 2020-10-15T10:40:13+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/02/shutterstock_767639497.jpg https://www.pharmadoc.it/c-e-s-e-leuropa-non-puo-perdere-competitivita-nel-settore-farmaceutico-necessaria-la-modifica-al-regolamento-sul-cpc/ 2020-10-15T10:40:29+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/01/Farmaci_mondo.jpg https://www.pharmadoc.it/passeranno-alla-convenzionata-i-farmaci-della-diretta-e-per-conto/ 2020-10-15T10:42:45+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/55952304_xl-copia.jpg https://www.pharmadoc.it/cresce-la-spesa-farmaceutica-nei-primi-10-mesi-del-2018/ 2020-10-15T10:43:04+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/03/Copia-di-Soldi-farmaci.jpg https://www.pharmadoc.it/tipologie-distributive-dei-farmaci-e-obiettivi-di-governance/ 2020-10-15T10:43:21+00:00 https://www.pharmadoc.it/wp-content/uploads/2019/02/shutterstock_248156353.jpg https://www.pharmadoc.it/wp-content/uploads/2019/02/tabella-1.png https://www.pharmadoc.it/wp-content/uploads/2019/02/figura1.png https://www.pharmadoc.it/wp-content/uploads/2019/02/fig-2.png https://www.pharmadoc.it/non-ce-due-senza-tre-in-arrivo-il-terzo-silos-nel-fondo-farmaci/ 2020-11-22T13:34:24+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/11/Silos-copia.jpg https://www.pharmadoc.it/accesso-ai-documenti-lirrilevanza-dellutilizzo-da-parte-del-terzo-richiedente/ 2020-11-24T08:13:05+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/11/Accesso-agli-atti-tibunale-EU.jpg https://www.pharmadoc.it/prime-norme-di-contingenza-per-il-sistema-di-acquisti-in-emergenza-sanitaria/ 2020-12-03T09:30:28+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/12/Cover-Amoroso-1.png https://www.pharmadoc.it/tutela-alla-salute-credo-religioso-e-sostenibilita-pubblica-delle-spese-sanitarie-la-corte-di-giustizia-su-un-caso-delicato/ 2020-12-09T13:48:04+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/12/Equality-Health.jpg https://www.pharmadoc.it/dopo-il-net-monetary-benefit-arriva-il-payment-by-result-regionale/ 2021-02-05T14:23:29+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/02/PbR.png https://www.pharmadoc.it/wp-content/uploads/2021/02/Managed-Entry-Agreements-1.png https://www.pharmadoc.it/wp-content/uploads/2021/02/Payment-by-result.png https://www.pharmadoc.it/wp-content/uploads/2021/02/Allegato-Payment-by-result.png https://www.pharmadoc.it/accordi-stragiudiziali-e-pratiche-anticoncorrenziali-la-stretta-europea-sulle-case-farmaceutiche/ 2021-04-12T16:46:27+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/04/Eu-e-Industria-Farcmaci.png https://www.pharmadoc.it/laifa-non-ci-sta-il-timeline-e-di-13-non-di-14-mesi/ 2021-07-19T10:31:59+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/07/TOJ.jpg https://www.pharmadoc.it/il-mercato-unico-non-deroga-allobbligo-dellaic/ 2021-07-27T08:53:36+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/07/EU_AIC_MercatoUnico.jpg https://www.pharmadoc.it/lindicazione-codice-atc-nella-descrizione-dei-lotti-di-gara/ 2021-09-01T15:37:42+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/07/ATC_LOTTI_GARA.jpg https://www.pharmadoc.it/anticorpi-anti-covid-19-long-acting-cocktail-combo/ 2021-09-03T09:46:32+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/12/vaccino-terapia.jpg https://www.pharmadoc.it/un-nuovo-farmaco-a-base-di-bevacizumab-sta-per-essere-immesso-sul-mercato-statunitense/ 2021-09-07T13:50:29+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/09/IN_LABEL_OFF_LABEL_DRUG.jpg https://www.pharmadoc.it/inversione-dellonere-della-prova-a-carico-di-aifa/ 2021-09-07T13:57:26+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/09/burden-of-proof.jpg https://www.pharmadoc.it/le-siringhe-luer-lock-per-il-vaccino-anti-covid/ 2021-09-07T14:01:24+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/01/Syringe-vaccine.jpg https://www.pharmadoc.it/wp-content/uploads/2021/01/Senza-titolo.png https://www.pharmadoc.it/wp-content/uploads/2021/01/siringa-componenti.png https://www.pharmadoc.it/wp-content/uploads/2021/01/dead-space-syringe.png https://www.pharmadoc.it/wp-content/uploads/2021/01/Siringhe-CND.png https://www.pharmadoc.it/privilegiata-la-liberta-prescrittiva-vs-la-medicina-basata-sulle-evidenze/ 2021-09-07T14:02:49+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/12/idrossiclorochina-2.jpg https://www.pharmadoc.it/aifa-consultazione-pubblica-sui-termini-del-negozio-dei-farmaci/ 2021-09-07T15:57:59+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/09/AIFA_INGRESSO.jpg https://www.pharmadoc.it/si-puo-restare-orfani-per-sempre-rispetto-a-quale-comparator-e-come-off-label-anche-nel-rcp-il-tribunale-europeo-prova-a-fare-chiarezza/ 2021-09-07T16:03:42+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/10/Tribunale-Europeo.jpg https://www.pharmadoc.it/i-prodotti-fuori-accordo-quadro-sono-prescrivibili-ma-non-concedibili-e-non-a-carico-del-ssn/ 2021-10-28T15:24:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/09/prezzo-base-dasta.jpg https://www.pharmadoc.it/wp-content/uploads/2020/09/Prezzi-base-dasta.png https://www.pharmadoc.it/diretta-pacta-non-sunt-servanda/ 2021-10-29T07:36:38+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/10/Diretta-pacta-non-sunt-servanda-copia.png https://www.pharmadoc.it/europa-nuova-strategia-per-luso-dei-farmaci/ 2021-12-10T08:13:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/12/STRATEGIA-FARMACEUTICA.jpeg https://www.pharmadoc.it/il-vecchio-modello-cipe-che-regola-la-stesura-dei-dossier-prezzo-e-rimborso-ritorna-in-vita/ 2022-01-05T10:42:17+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/07/VignettaNEW.png https://www.pharmadoc.it/la-creazione-della-lista-di-identicita-di-prezzo-e-una-scelta-arbitraria-di-aifa/ 2022-01-19T10:23:39+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/01/Lista-Identicita-Prezzo.png https://www.pharmadoc.it/nota-13-aifa-rivede-le-sue-posizioni-rispetto-alle-combinazioni-in-dose-fissa-di-statine-ed-ezetimide/ 2022-01-21T08:50:25+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/05/ricetta-prescrizione-37837146_I-copia.jpg https://www.pharmadoc.it/wp-content/uploads/2020/05/Tabella-1.png https://www.pharmadoc.it/wp-content/uploads/2020/05/Tabella-2.png https://www.pharmadoc.it/wp-content/uploads/2020/05/Tabella-3.png https://www.pharmadoc.it/wp-content/uploads/2020/05/Tabella-4.png https://www.pharmadoc.it/wp-content/uploads/2020/05/Tabella-5.png https://www.pharmadoc.it/la-delibera-cipe-e-stata-definitivamente-affossata-dal-consiglio-di-stato/ 2022-01-24T16:39:24+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/01/CIPE-vade-retro.jpg https://www.pharmadoc.it/distribuzionediretta-e-distribuzioneperconto-nel-mirino/ 2022-01-28T08:41:09+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/01/DD_DPC_VS_CONVENZIONATA.png https://www.pharmadoc.it/equivalenza-terapeutica-e-codice-dei-contratti/ 2022-01-28T11:34:54+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/03/Equivalenza-terapeutica-e-codice-dei-contratti-copia.jpg https://www.pharmadoc.it/dispositivi-medici-la-cnd-si-aggiorna/ 2022-02-15T13:48:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/02/DM-classificazione-aggiornata.png https://www.pharmadoc.it/cammelli-e-covid-19-le-strane-congiunzioni/ 2022-03-28T13:16:13+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/10/Covid-Free-copia.jpg https://www.pharmadoc.it/sostenibilita-e-innovazione-tecnologica-concorrenza-e-profittabilita/ 2022-03-28T15:00:36+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/02/SOSTENIBILITA-INNOVAZIONE.png https://www.pharmadoc.it/tamponi-anti-covid-e-la-guerra-fratricida-tra-farmacie-e-parafarmacie/ 2022-03-28T15:03:00+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/01/Farmacie-parafarmacie-tamponi-rapidi-Covid.png https://www.pharmadoc.it/base-dasta-e-valore-della-fornitura-negli-appalti-pubblici-il-percorso-valutativo-nel-caso-del-farmaco/ 2022-03-28T15:04:00+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/02/Tender_base_asta.png https://www.pharmadoc.it/cts-scomparira-forse-la-commissione-tecnico-scientifica-di-aifa/ 2022-03-28T15:05:28+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/02/CTS_CPR_EU-HTA.png https://www.pharmadoc.it/ema-e-obblighi-vaccinali-cerchiamo-di-fare-un-po-di-chiarezza/ 2022-04-11T09:48:11+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/04/EU_tribunale_vaccini_covid_19.png https://www.pharmadoc.it/i-giudici-amministrativi-intervengono-su-elementi-di-governance-farmaceutica-regionale/ 2022-04-26T07:10:28+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/04/prescrizione.png https://www.pharmadoc.it/pillola-del-giorno-dopo-il-cds-mette-un-pietra-tombale-sulle-posizioni-dei-movimenti-per-la-vita/ 2022-05-02T15:03:27+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/05/Cicogna-Dau-After-Pillow.png https://www.pharmadoc.it/wp-content/uploads/2022/04/TABELLA-1.png https://www.pharmadoc.it/il-codice-atc-di-v-livello-non-e-elemento-sufficiente-per-gare-in-equivalenza-terapeutica-tra-atc-inn-nas-e-kas-il-caso-del-fattore-viii-di-coagulazione/ 2022-05-05T13:44:15+00:00 https://www.pharmadoc.it/wp-content/uploads/2021/11/FATTORE-VIII_ATC_EMOFILIA-1.png https://www.pharmadoc.it/nellequivalenza-terapeutica-non-ce-inversione-dellonere-della-prova/ 2022-05-05T13:48:23+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/09/Equivalenza-Terapeutica-1.jpg https://www.pharmadoc.it/accordo-quadro-e-confronto-competitivo-il-piemonte-dice-basta-alle-clausole-correttive-saves-all/ 2022-05-05T13:53:47+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Schermata-2020-07-27-alle-17.27.07.png https://www.pharmadoc.it/innovativo-o-non-innovativo-questo-e-il-problema/ 2022-05-09T12:42:49+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/01/Schermata-2022-01-24-alle-16.28.07.png https://www.pharmadoc.it/brevetto-europeo-con-effetto-unitario-implicazioni-di-uno-strumento-rivoluzionario/ 2022-05-17T08:41:24+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/05/European-Patent-Office.jpg https://www.pharmadoc.it/il-consiglio-di-stato-bacchetta-il-ministero-sui-modelli-del-piano-per-lassistenza-territoriale-i-difetti-e-lassenza-di-un-cronoprogramma/ 2022-05-24T08:54:10+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/05/PNRR_assitenza-territoriale.png https://www.pharmadoc.it/cultura-assistenziale-unica-attraverso-lintegrazione-tra-assistenza-territoriale-e-ospedaliera-2/ 2022-07-05T14:08:16+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/06/Cover-Pisterna.png https://www.pharmadoc.it/il-prontuario-terapeutico-come-strumento-di-governance-farmaceutica/ 2022-07-05T14:09:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/06/Dott.ssa-De-Francesco.png https://www.pharmadoc.it/cultura-assistenziale-unica-attraverso-lintegrazione-tra-assistenza-territoriale-e-ospedaliera/ 2022-07-05T14:11:09+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/05/Cover-vagnini.png https://www.pharmadoc.it/verso-un-modello-di-governance-farmaceutica-unitario/ 2022-07-05T14:12:23+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/06/Moscogiuri.png https://www.pharmadoc.it/un-sistema-sostenibile-e-universalistico-di-presa-in-carico-dei-pazienti-cronici/ 2022-07-06T10:01:29+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Dott_Ugo_Trama.png https://www.pharmadoc.it/valutazioni-individuali-e-collegiali-delle-commissioni-di-gara-il-cds-chiede-lintervento-delladunanza-plenaria/ 2022-07-11T10:00:52+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/07/collegiale_vs_individuale.png https://www.pharmadoc.it/roche-novartis-vs-agcm-il-caso-lucentis-avastin-alle-battute-finali/ 2022-07-22T09:51:37+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/07/Avastin_Luventis_Off_Label.png https://www.pharmadoc.it/la-preminenza-della-potesta-prescrittiva/ 2022-09-14T08:41:27+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/09/Accordi-_quadro_Liguria.png https://www.pharmadoc.it/wp-content/uploads/2022/09/accordi_quadro_interpretazioni.png https://www.pharmadoc.it/wp-content/uploads/2022/09/Accordo-quadro_asta.png https://www.pharmadoc.it/lotti-composti-quando-si-puo-aggiudicare-a-lotti-interi-e-non-per-sublotti-i-casi-lenalidomide-e-nitisinone/ 2022-09-15T09:44:17+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/09/Lotti_sublotti_pharmadoc.png https://www.pharmadoc.it/intercambiabilita-a-livello-di-farmacia-dei-biosimilari-nei-paesi-europei-in-italia-solo-se-cambia-la-legge-che-la-vieta-espressamente/ 2022-09-27T11:16:33+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/09/Intercambiabilita%CC%80-evoluzione-e1664276211723.png https://www.pharmadoc.it/le-strategie-vincenti-di-gara-dei-soggetti-aggregatori-come-elevare-a-concorrenza-ed-abbassare-i-prezzi-di-aggiudicazione/ 2022-11-07T09:32:15+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/10/Strategia_acquisti.png https://www.pharmadoc.it/brevetti-divisionali-il-caso-teva-in-europa/ 2022-11-07T11:26:40+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/11/Antitrust_brevetti.png https://www.pharmadoc.it/wp-content/uploads/2022/11/Tabella-1.png https://www.pharmadoc.it/la-lunga-marcia-delle-parafarmacie-al-riconoscimento-professionale/ 2022-11-09T11:54:23+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/11/Parafarmacie.jpeg https://www.pharmadoc.it/la-governance-farmaceutica-umbra-provvedimenti-taglia-spese-o-taglia-diritti/ 2022-12-01T11:53:59+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/12/Umbria-Governance.png https://www.pharmadoc.it/wp-content/uploads/2022/12/Tabella-1.png https://www.pharmadoc.it/wp-content/uploads/2022/12/Tabella-2.png https://www.pharmadoc.it/associazioni-fisse-e-lista-di-trasparenza-adesso-e-tutto-chiaro/ 2022-12-07T11:04:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2022/12/ASSOCIAZIONI-E-LISTA-DI-TRASPARENZA.png https://www.pharmadoc.it/wp-content/uploads/2022/12/Liste-di-trasparenza.png https://www.pharmadoc.it/va-in-pensione-la-delibera-cipe-3-2001-ora-occhi-puntati-sullattuazione-del-programma-aifa/ 2022-12-07T12:15:45+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/07/Delibera-CIPE.jpg https://www.pharmadoc.it/wp-content/uploads/2020/07/Senza-titolo.png https://www.pharmadoc.it/mascherine-e-dpi-ai-tempi-del-coronavirus/ 2022-12-08T14:55:40+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/03/Copia-di-89186420_xl-mascherine.jpg https://www.pharmadoc.it/acquisti-urgenti-di-beni-sanitari-allepoca-del-coronavirus/ 2022-12-09T14:59:22+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/04/144440425_l-copia.jpg https://www.pharmadoc.it/vaccinazioni-anche-in-farmacia-oltre-il-divieto-per-emergenza-sanitaria/ 2022-12-09T15:07:45+00:00 https://www.pharmadoc.it/wp-content/uploads/2020/06/vaccinazione-Pro-2020rev-copia.jpg https://www.pharmadoc.it/lattivita-valutativa-dei-commissari-ladunanza-plenaria-enuncia-i-principi-interpretativi/ 2023-01-16T12:20:07+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/01/Consiglio-di-Stato_adunanza_plenaria.png https://www.pharmadoc.it/il-farmaco-puoi-ritirarlo-adesso-anche-dal-macellaio/ 2023-01-31T15:26:19+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/01/farmacia-e-macelleria.png https://www.pharmadoc.it/registri-dei-farmaci-orfani-e-orphan-like-differenze-e-ricadute/ 2023-02-16T09:33:35+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/02/Orphan-like_farmaci-orfani-1.png https://www.pharmadoc.it/wp-content/uploads/2023/02/Schermata-2023-02-15-alle-15.20.26.png https://www.pharmadoc.it/il-back-up-come-strumento-potenzialmente-collusivo-tra-le-imprese-a-fini-anticoncorrenziali/ 2023-02-23T13:30:02+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/02/AGCM_RADIOFARMACI_ARTICOLO_PHARMADOC_ANTITRUST.png https://www.pharmadoc.it/wp-content/uploads/2023/02/Back-up_Soggetti_coinvolti_AGCM_Pharmadoc_articolo-1-e1677142846673.png https://www.pharmadoc.it/wp-content/uploads/2023/02/Schermata-2023-02-23-alle-09.49.27.png https://www.pharmadoc.it/protestare-paga-1-085-milioni-e-lammontare-del-contributo-statale-al-pagamento-del-payback-dm-agli-industriali-del-biomedicale/ 2023-04-05T08:47:10+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/04/Screenshot-2023-04-05-alle-10.24.05.png https://www.pharmadoc.it/nuova-remunerazione-aggiuntiva-alle-farmacie-per-la-dispensazione-di-farmaci-in-regime-di-ssn-conferma-del-mix-remunerativo-percentuale-prestazionale/ 2023-06-01T08:03:41+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/06/emunerazione-aggiuntiva-alle-farmacie.png https://www.pharmadoc.it/come-fare-a-mantenere-il-market-share-a-distanza-di-anni-dalla-perdita-di-brevetto-del-prodotto-un-caso-di-scuola/ 2023-06-14T14:35:14+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/06/MarketShare-Originator-Biosimilare.png https://www.pharmadoc.it/aifa-piano-di-attivita-2023/ 2023-06-15T09:09:53+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/06/AIFA-PIAO-2023.png https://www.pharmadoc.it/wp-content/uploads/2023/06/Organigramma-AIFA.png https://www.pharmadoc.it/wp-content/uploads/2023/06/Mision-ed-obiettivi-2023.png https://www.pharmadoc.it/wp-content/uploads/2023/06/Mission-e-direttrici-2022.png https://www.pharmadoc.it/le-consenguenze-della-esclusione-di-forsteo-e-generici-di-sintesi-chimica-dalla-lista-di-trasparenza/ 2023-10-12T11:07:44+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/10/Lista-trasparenza.png https://www.pharmadoc.it/abrogazione-dei-ptor-e-il-turno-della-sardegna/ 2023-12-15T12:06:51+00:00 https://www.pharmadoc.it/wp-content/uploads/2023/12/PTR-Sardegna.png https://www.pharmadoc.it/wp-content/uploads/2023/12/PTOR_SARDEGNA_23.png https://www.pharmadoc.it/nuovi-biosimilari-in-vista-in-europa-accordo-tra-formycon-e-g-richter/ 2024-02-22T10:09:40+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/02/BIOSIMILA-DRUGS.png https://www.pharmadoc.it/wp-content/uploads/2024/02/Tabella-1-New-Biosimilar.png https://www.pharmadoc.it/wp-content/uploads/2024/02/Pipeline-Formycon.png https://www.pharmadoc.it/lattribuzione-degli-incarichi-di-rup-suscita-la-protesta-di-tutti-i-direttori-delle-farmacie-ospedaliere-della-regione-marche/ 2024-03-08T14:10:29+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/03/Farmaciti-Rup.png https://www.pharmadoc.it/arriva-anche-in-europa-lapprovazione-del-bevacizumab-intravitreale/ 2024-03-26T16:08:34+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/03/Lytenava.png https://www.pharmadoc.it/il-sunshine-act-incombe/ 2024-04-09T08:48:48+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/04/SunshineAct_24.png https://www.pharmadoc.it/intesa-tra-aziende-farmaceutiche-per-ritardare-lingresso-sul-mercato-di-prodotti-biosimilari/ 2024-06-11T17:00:11+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/06/Screenshot-2024-06-11-alle-18.37.50.png https://www.pharmadoc.it/wp-content/uploads/2024/06/Comunicato-Stampa-AGCM-1.png https://www.pharmadoc.it/payback-farmaceutico-si-avvicina-un-ulteriore-smantellamento-della-governance-farmaceutica-pubblica/ 2024-07-12T13:21:12+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/07/Screenshot-2024-07-12-alle-15.19.20.png https://www.pharmadoc.it/wp-content/uploads/2024/07/Screenshot-2024-07-12-alle-09.19.34.png https://www.pharmadoc.it/wp-content/uploads/2024/07/Farmaceutica-Osnato.png https://www.pharmadoc.it/payback-dm-interviene-la-corte-costituzionale-e-scontenta-tutti/ 2024-07-26T06:10:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/07/PayBack-DM.png https://www.pharmadoc.it/lo-sviluppo-della-farmacia-dei-servizi-in-regione-emilia-romagna/ 2024-08-13T09:54:25+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/08/Screenshot-2024-08-13-alle-11.46.31.png https://www.pharmadoc.it/wp-content/uploads/2024/08/Screenshot-2024-08-13-alle-11.11.37.png https://www.pharmadoc.it/sardegna-il-ptr-redivivo-ma-senza-ctr/ 2024-09-03T10:47:01+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/09/PTR-SARDEGNA-1.png https://www.pharmadoc.it/wp-content/uploads/2024/09/RIUNIONI-PTR.png https://www.pharmadoc.it/wp-content/uploads/2024/09/Screenshot-2024-09-01-alle-10.19.48.png https://www.pharmadoc.it/il-filo-di-arianna-nel-farmaceutico/ 2024-09-13T10:19:39+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/09/Screenshot-2024-09-13-alle-12.18.15.png https://www.pharmadoc.it/se-e-di-vetro-ti-escludo-e-non-lo-puoi-fornire-il-cds-convalida-la-posizione-della-regione-liguria-per-il-prodotto-a-base-di-sevoflurano/ 2024-10-09T10:41:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2024/10/SEVOFLURANO.png https://www.pharmadoc.it/payback-dm-il-tar-mette-la-parola-fine-o-forse-no/ 2025-05-12T10:17:50+00:00 https://www.pharmadoc.it/wp-content/uploads/2025/05/Payback-DM-2025.png https://www.pharmadoc.it/il-risparmio-potenziale-nellacquisto-del-metadone/ 2025-05-28T09:00:27+00:00 https://www.pharmadoc.it/wp-content/uploads/2025/05/metadone_compresse_fiale.png https://www.pharmadoc.it/wp-content/uploads/2025/05/Tabella_1.png https://www.pharmadoc.it/wp-content/uploads/2025/05/Gara-PuntoZero-2023.png https://www.pharmadoc.it/wp-content/uploads/2025/05/Gara-Aria-2022.png https://www.pharmadoc.it/wp-content/uploads/2025/05/Tabella-2.png https://www.pharmadoc.it/wp-content/uploads/2025/05/Tabella-3.png https://www.pharmadoc.it/wp-content/uploads/2025/05/Tabella-4.png https://www.pharmadoc.it/nella-riforma-ricanalizzativa-dei-farmaci-scompare-la-formula-dellinvarianza-di-spesa-gli-aumenti-a-danno-del-ssn-si-danno-per-scontati/ 2025-07-14T09:50:20+00:00 https://www.pharmadoc.it/wp-content/uploads/2025/07/spesa-farmaceutica-SSN-scaled.jpg https://www.pharmadoc.it/interpretazione-del-correttivo-al-codice-dei-contratti-a-proposito-di-accordo-quadro-farmaci-biotecnologici/ 2025-11-05T07:47:47+00:00 https://www.pharmadoc.it/wp-content/uploads/2025/11/correttivo-Codice-Appalti.png https://www.pharmadoc.it/il-presidente-della-sicilia-sgancia-una-bomba-sulla-controriforma-targata-gemmato/ 2025-12-01T13:24:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2025/12/Regioni-vs-Determina-AIFA.png https://www.pharmadoc.it/la-tripartizione-delle-quote-nelle-gare-in-aq-nazionalizzato-il-modello-toscano/ 2026-01-15T10:52:46+00:00 https://www.pharmadoc.it/wp-content/uploads/2026/01/Evoluzione-sistema-acquiasto-farmaci-e1767440170805.png https://www.pharmadoc.it/wp-content/uploads/2026/01/Confronto-posizioni-Farmindustria.png https://www.pharmadoc.it/il-vuoto-dei-biosimilari/ 2026-01-28T14:01:13+00:00 https://www.pharmadoc.it/wp-content/uploads/2025/11/il-vuoto-di-biosimilari.jpg https://www.pharmadoc.it/legge-di-bilancio-2026-le-ricadute-sulla-farmaceutica/ 2026-03-20T08:28:23+00:00 https://www.pharmadoc.it/wp-content/uploads/2026/01/Legge-di-Bilancio-e1768399474471.png https://www.pharmadoc.it/la-concorrenza-dei-biosimilari/ 2026-03-20T08:29:18+00:00 https://www.pharmadoc.it/wp-content/uploads/2026/01/La-concorrenza-dei-biosimilari-scaled.jpg https://www.pharmadoc.it/nuova-nota-n01-rischio-di-inappropriatezza-prescrittiva-e-di-ricorso-alla-legge-648-96/ 2026-03-20T14:28:05+00:00 https://www.pharmadoc.it/wp-content/uploads/2026/03/Screenshot-2026-03-20-alle-13.31.12-e1774009972392.png https://www.pharmadoc.it/wp-content/uploads/2026/03/NOTA-01-AIFA-2026.png https://www.pharmadoc.it/wp-content/uploads/2026/03/BOX-2-NOTE-AIFA-2025.png https://www.pharmadoc.it/il-processo-di-velocizzazione-delle-pratiche-aifa-arrivano-procedure-semplificate-e-fast-track/ 2026-03-25T16:54:54+00:00 https://www.pharmadoc.it/wp-content/uploads/2026/03/AIFA-nuove-procedure-negoziazione.png